Heart, Lung and Circulation
Original Article| Volume 18, ISSUE 5, P330-333, October 2009

A Comparison of Risk Factors for Coronary Heart Disease and Ischaemic Stroke: The Dubbo Study of Australian Elderly


      Conventional risk factors for coronary heart disease (CHD) and ischaemic stroke (IS) have been well documented. This study examines whether there is a unique pattern of risk factors for each disease.


      This is a prospective cohort study in Dubbo NSW which has followed 2805 men and women 60 years and older for 16 years since 1988–1989. CHD and IS events were identified by hospital record linkage. The independent contributions of risk factors to these events were evaluated in proportional hazards regression models.


      CHD events (without stroke) occurred in 853 subjects (30.4/100). IS events (without CHD) occurred in 185 subjects (6.6/100). Some risk factors produced broadly similar prediction of CHD and IS events (male sex, current smoking, diabetes, LDL cholesterol, reduced peak expiratory flow, physical disability). Other factors potentially produced unique prediction of CHD (CHD at baseline, family history of CHD, HDL cholesterol, ApoB/ApoA1 ratio) or IS (stroke at baseline), or stronger prediction of IS compared with CHD (age, hypertension, atrial fibrillation).


      CHD and IS may each have some unique predictors, but treatable risk factors have been demonstrated for both cardiovascular outcomes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Libby P.
        The pathogenesis, prevention and treatment of atherosclerosis.
        in: Fauci A.S. Kasper D.L. Longo D.L. Braunwald E. Hauser S.L. Jameson J.L. Loscalzo J. Harrison's principles of internal medicine. 17th Edition. McGraw-Hill, New York2008: 1501-1509
        • Simons L.A.
        • Friedlander Y.
        • McCallum J.
        • Simons J.
        Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly.
        Atherosclerosis. 1995; 117: 107-118
        • Simons L.A.
        • McCallum J.
        • Friedlander Y.
        • Simons J.
        Risk factors for ischemic stroke. Dubbo Study of the Elderly.
        Stroke. 1998; 29: 1341-1346
        • Simons L.A.
        • McCallum J.
        • Friedlander Y.
        • Simons J.
        • Powell I.
        • Heller R.
        Dubbo Study of the elderly: sociological and cardiovascular risk factors at entry.
        Aust NZ J Med. 1991; 21: 701-709
        • Martin R.
        • Bogousslovsky J.
        Embolic versus nonembolic causes of ischemic stroke.
        Cerebrovasc Dis. 1995; 5: 70-74
      1. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986;43:71–84.

        • McQueen M.J.
        • Hawken S.W.
        • Wang X.
        • Ounpuu S.
        • Sniderman A.
        • Probstfield J.
        • Steyn K.
        • Sanderson J.E.
        • Hasani M.
        • Volkova E.
        • Kazmi K.
        • Yusuf S
        • for the INTERHEART study investigators
        Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case–control study.
        Lancet. 2008; 372: 224-233
        • Simons L.A.
        • McCallum J.
        • Simons J.
        • Powell I.
        • Ruys J.
        • Heller R.F.
        • Lerba C.
        The Dubbo Study: an Australian prospective community study of the health of elderly.
        Aust NZ J Med. 1990; 20: 783-789
        • Critchley J.A.
        • Capewell S.
        Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.
        JAMA. 2003; 290: 86-97
        • Kenfield S.A.
        • Stampfer M.J.
        • Rosner B.A.
        • Colditz G.
        Smoking and smoking cessation in relation to mortality in women.
        JAMA. 2008; 299: 2037-2047
        • Gudmundsson L.S.
        • Johannsson M.
        • Thorgeirsson G.
        • Sigfusson N.
        • Sigvaldsson H.
        • Witteman J.C.
        Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykjavik Study.
        J Hum Hypertens. 2004; 18: 615-622
        • Moye L.A.
        • Davis B.R.
        • Hawkins C.M.
        • Probstfield J.L.
        Conclusions and implications of the systolic hypertension in the elderly program.
        Clin Exp Hypertens. 1993; 15: 911-924
        • Indik J.H.
        • Alpert J.S.
        The patient with atrial fibrillation.
        Am J Med. 2009; 122: 415-418
        • Baigent C.
        • Keech A.
        • Kearney P.M.
        • Blackwell L.
        • Buck G.
        • Pollicino C.
        • Kirby A.
        • Sourjina T.
        • Peto R.
        • Collins R.
        • Simes R.
        • Cholesterol Treatment Trialists’ (CTT) Collaborators
        Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
        Lancet. 2005; 366: 1267-1278